Drug Profile
MPC SHRC
Alternative Names: MPC HSRC-Mission Pharmacal; MPC-SHRC; MPCHSRCLatest Information Update: 28 May 2021
Price :
$50
*
At a glance
- Originator Mission Pharmacal
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Urinary tract infections
Most Recent Events
- 28 May 2021 No recent reports of development identified for preclinical development in Urinary-tract-infections in USA (PO, Tablet)
- 19 Apr 2017 Preclinical trials in Urinary tract infections in USA prior to April 2017 (PO)
- 19 Apr 2017 Mission Pharmacal plans a phase II proof of concept trial for Urinary tract infections in USA (NCT03129295)